MMP13 and osteoarthritis: In knee osteoarthritis, administration of exogenous miR-17 downregulated the expression of pathological catabolic factors such as MMP13, ADAMTS5, and NOS2, thereby reducing extracellular matrix damage and alleviating the severity of osteoarthritis [24].